Display options
Share it on

BMC Med Genomics. 2008 Aug 18;1:38. doi: 10.1186/1755-8794-1-38.

Tobacco use induces anti-apoptotic, proliferative patterns of gene expression in circulating leukocytes of Caucasian males.

BMC medical genomics

Peter C Charles, Brian D Alder, Eleanor G Hilliard, Jonathan C Schisler, Robert E Lineberger, Joel S Parker, Sabeen Mapara, Samuel S Wu, Andrea Portbury, Cam Patterson, George A Stouffer

Affiliations

  1. Carolina Cardiovascular Biology Center, University of North Carolina at Chapel Hill, Chapel Hill, USA. [email protected]

PMID: 18710571 PMCID: PMC2531187 DOI: 10.1186/1755-8794-1-38

Abstract

BACKGROUND: Strong epidemiologic evidence correlates tobacco use with a variety of serious adverse health effects, but the biological mechanisms that produce these effects remain elusive.

RESULTS: We analyzed gene transcription data to identify expression spectra related to tobacco use in circulating leukocytes of 67 Caucasian male subjects. Levels of cotinine, a nicotine metabolite, were used as a surrogate marker for tobacco exposure. Significance Analysis of Microarray and Gene Set Analysis identified 109 genes in 16 gene sets whose transcription levels were differentially regulated by nicotine exposure. We subsequently analyzed this gene set by hyperclustering, a technique that allows the data to be clustered by both expression ratio and gene annotation (e.g. Gene Ontologies).

CONCLUSION: Our results demonstrate that tobacco use affects transcription of groups of genes that are involved in proliferation and apoptosis in circulating leukocytes. These transcriptional effects include a repertoire of transcriptional changes likely to increase the incidence of neoplasia through an altered expression of genes associated with transcription and signaling, interferon responses and repression of apoptotic pathways.

References

  1. Immunogenetics. 2007 Jan;59(1):37-43 - PubMed
  2. PLoS Med. 2004 Oct;1(1):e8 - PubMed
  3. Clin Infect Dis. 2005 Nov 15;41 Suppl 7:S427-35 - PubMed
  4. Bioinformatics. 2006 Dec 1;22(23):2926-33 - PubMed
  5. Methods Mol Biol. 2003;224:149-57 - PubMed
  6. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 - PubMed
  7. Clin Chem. 2004 Aug;50(8):1464-71 - PubMed
  8. J Cell Mol Med. 2006 Jul-Sep;10(3):554-68 - PubMed
  9. J Biol Chem. 2005 Jul 29;280(30):28152-61 - PubMed
  10. Bioinformatics. 2007 Dec 1;23(23):3251-3 - PubMed
  11. Circulation. 2006 Aug 22;114(8):807-19 - PubMed
  12. Methods. 2003 Dec;31(4):265-73 - PubMed
  13. Carcinogenesis. 2004 Nov;25(11):2275-81 - PubMed
  14. Chest. 2003 Jan;123(1 Suppl):21S-49S - PubMed
  15. Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):200-8 - PubMed
  16. N Engl J Med. 2006 Aug 10;355(6):560-9 - PubMed
  17. Cancer Causes Control. 1997 May;8(3):406-19 - PubMed
  18. Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3423-8 - PubMed
  19. Int J Mol Med. 2004 Apr;13(4):483-95 - PubMed
  20. Am J Physiol Lung Cell Mol Physiol. 2007 May;292(5):L1248-56 - PubMed
  21. Nucleic Acids Res. 2006 Jan 1;34(Database issue):D108-10 - PubMed
  22. J Natl Cancer Inst. 1993 Dec 15;85(24):1994-2003 - PubMed
  23. Biomarkers. 2003 May-Aug;8(3-4):187-203 - PubMed
  24. Br J Cancer. 2006 Nov 20;95(10):1419-23 - PubMed
  25. Oral Microbiol Immunol. 2004 Feb;19(1):39-49 - PubMed
  26. J Mol Med (Berl). 2006 Apr;84(4):318-28 - PubMed
  27. Ann Med. 2005;37(5):323-32 - PubMed
  28. Physiol Genomics. 2004 Nov 17;19(3):247-54 - PubMed
  29. Nat Genet. 2000 May;25(1):25-9 - PubMed
  30. Circulation. 1996 Feb 1;93(3):450-6 - PubMed
  31. Bioinformatics. 2004 Nov 22;20(17):3246-8 - PubMed
  32. Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):445-53 - PubMed
  33. J Lab Clin Med. 2006 Mar;147(3):126-32 - PubMed
  34. Eur J Epidemiol. 2004;19(7):679-86 - PubMed
  35. Toxicol Sci. 2005 Jul;86(1):200-10 - PubMed
  36. Am J Public Health. 1998 Oct;88(10):1503-9 - PubMed
  37. J Cell Sci. 1999 Jul;112 ( Pt 13):2223-32 - PubMed
  38. Nucleic Acids Res. 2001 Jan 1;29(1):281-3 - PubMed
  39. Gene. 2005 Jun 6;352:75-81 - PubMed
  40. Bioinformatics. 2005 May 1;21(9):1943-9 - PubMed
  41. Eur Heart J. 2000 Oct;21(19):1621-6 - PubMed
  42. Carcinogenesis. 2007 Mar;28(3):691-7 - PubMed
  43. Pharmacogenomics J. 2002;2(2):111-6 - PubMed
  44. J Mol Med (Berl). 2007 Jan;85(1):39-53 - PubMed
  45. BMJ. 2004 Jan 24;328(7433):217-9 - PubMed
  46. Nucleic Acids Res. 2003 Jan 1;31(1):374-8 - PubMed
  47. Toxicol Sci. 2003 Jan;71(1):11-9 - PubMed
  48. Exp Nephrol. 2002;10(2):139-49 - PubMed
  49. BMC Genomics. 2004 Mar 09;5(1):20 - PubMed
  50. Tob Control. 2003 Jun;12(2):178-83 - PubMed
  51. Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8 - PubMed
  52. Mol Hum Reprod. 2006 Nov;12(11):655-60 - PubMed
  53. Heart. 2003 Jun;89(6):597-604 - PubMed
  54. J Am Coll Cardiol. 2006 Jul 18;48(2):227-35 - PubMed
  55. Med Clin North Am. 1992 Mar;76(2):305-31 - PubMed
  56. Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21 - PubMed
  57. MMWR Morb Mortal Wkly Rep. 2006 Oct 27;55(42):1145-8 - PubMed
  58. J Plast Reconstr Aesthet Surg. 2006;59(11):1156-61 - PubMed
  59. Clin Cancer Res. 2005 Feb 1;11(3):1181-9 - PubMed
  60. Free Radic Biol Med. 2007 Aug 1;43(3):415-22 - PubMed
  61. Leukemia. 2007 Jun;21(6):1137-40 - PubMed
  62. J Exp Med. 2003 Mar 17;197(6):711-23 - PubMed

Publication Types

Grant support